CatalystAlert

CatalystAlert serves as a biotech catalyst tracking platform designed for investors interested in monitoring market-moving events in the biopharmaceutical sector. It provides a comprehensive calendar that tracks key events such as FDA PDUFA decision dates, Phase 1/2/3 clinical trial results, FDA advisory committee meetings, NDA/BLA filings, earnings reports, conference presentations, EMA approvals, and other regulatory milestones for over 1,700 biotechnology companies. Each event date is assigned a confidence rating—confirmed, estimated, or AI-detected—based on aggregation from official sources including ClinicalTrials.gov, SEC EDGAR filings, the FDA openFDA database, EMA, and company press releases, giving users insight into the reliability of each catalyst.

The platform leverages AI-powered predictions to help investors anticipate potential stock price movements resulting from these catalysts. Machine learning models are trained on historical catalyst outcomes and price data, and a feature called Likelihood of Approval (LOA) provides a probability score estimating the chance of FDA approval for a drug, factoring in clinical phase, therapeutic area, trial design, and special regulatory designations. These models are calibrated against industry benchmarks and retrained weekly as new data becomes available. CatalystAlert also offers structured educational content through its Biotech Academy, which covers biotech fundamentals in areas such as FDA regulation, clinical trials, gene therapy, oncology, mergers and acquisitions, and market dynamics, with interactive quizzes and real-world scenarios to aid learning.

Investors can search for companies, drugs, and catalysts, create personalized watchlists, and receive real-time alerts and weekly digests about upcoming events. The core data is updated every 2-6 hours, ensuring timely information, and push notifications can be enabled for instant alerts on approaching catalysts, announced results, or significant price movements. The platform emphasizes that it is informational only and does not provide financial advice.

CatalystAlert is delivered as a web-based service. It offers a free tier with a 7-day catalyst calendar view, company search, and watchlist features. The Pro plan, priced at $29.99 per month, unlocks access to the full calendar, AI predictions, and real-time alerts, and includes a 48-hour free trial. An Elite tier with API access is announced as coming soon at a higher subscription rate.